Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.


Surmell Z. G., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.28, sa.15, 2010 (SCI-Expanded) identifier